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Lawsonia intracellularis is an anaerobic obligate intracellular bacterium infecting the small
intestine and infrequently also the large intestine of pigs and other animals including
hamsters and horses. The infection is characterized by proliferation, hemorrhage,
necrosis, or any combination commonly referred to as “ileitis,” affecting the health and
production efficacy of farmed pigs. Despite decades of research on this pathogen,
the pathogenesis and virulence factors of this organism are not clearly known. In
pigs, prophylaxis against L. intracellularis infection is achieved by either administration
of subtherapeutic levels of in-feed antibiotic growth promoters or vaccination. While
the former approach is considered to be effective in L. intracellularis control, potential
regulations on subtherapeutic antibiotics in many countries in the near future may
necessitate alternative approaches. The potential of manipulating the gut microbiome of
pigs with feed ingredients or supplements to control L. intracellularis disease burden is
promising based on the current understanding of the porcine gut microbiome in general,
as well as preliminary insights into the disease ecology of L. intracellularis infection
accrued over the last 30 years.
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INTRODUCTION
Enteric diseases in pigs, especially around weaning, are very common and often of infectious nature
(1). While viruses play a main role in young pigs, bacteria and protozoa are often contributing to
diarrhea and related clinical signs and subsequent reduction of average daily gain in growing pigs.
Among economically important bacteria, Lawsonia intracellularis (L. intracellularis) is prevalent
worldwide and the infection manifests in pigs in two clinical presentations (2). The chronic
proliferative form of L. intracellularis infection, described as proliferative enteropathy (PE) or
porcine PE (PPE), is commonly observed in weaned and growing pigs less than 4 months of age.
It is associated with decreased weight gain and low mortality due to proliferation and thickening
of the ileum and the proximal colon. Acute L. intracellularis infection is known as proliferative
hemorrhagic enteritis (PHE), and is characterized by intestinal hemorrhages and sudden death,
usually occurring in mature pigs older than 4 months (2).
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Initial Clinical Characterization and
Isolation of L. intracellularis
Occurrence of intestinal adenoma in swine, described as
“degeneration of the epithelium, formation of adenomatous
growths and transition from goblet cells to undifferentiated
non-mucin-containing cells in the ileum and colon” was first
documented in 1931 (Figure 1) by investigators from the
Department of Veterinary Investigation, Iowa State College,
Ames, Iowa, USA (3). The authors describe experimental
reproduction of this disease in 12 pigs, by “feeding intestinal
contents and scrapings from themucosa of infected swine,” which
manifested as acute dysentery and proliferative epithelial lesions
in the intestines (3). This seminal work proved the infectious
nature of “porcine intestinal adenoma” now known as PE. In
1973, researchers from the Royal (Dick) School of Veterinary
Studies, Edinburgh, UK, identified with electron microscopy
“an irregularly curved bacterium” in affected intestinal epithelial
cells of pigs with PHE (4). Staining of affected intestinal
epithelium cells with fluorophore labeled serum from affected
pigs revealed specific signals in their apical cytoplasm (4,
5). In 1989, the same research group was able to identify
Campylobacter-like organisms in the cytoplasm of enterocytes in
gnotobiotic pigs experimentally infected with intestinal mucosa
homogenate from a pig with PHE (6). They suggested that these
organisms enter the enterocytes and multiply intracellularly in
affected tissues after invasion. Axenic culture of the intracellular
organism in conventional culture medium could not be achieved
(6). A disease similar to PHE, transmissible ileal hyperplasia
(TIH), was known in hamsters since 1965 (7). Similar to
PHE, light and fluorescent microscopic observations in affected
hamsters showed curved rod-shaped bacteria located in the
apical cytoplasm of immature crypt epithelial cells in the ileum
(5, 7–9). The TIH associated bacteria were thought to replicate
intracellularly, and appeared to accumulate in hyperplastic
epithelial cells (5). Oral inoculation of hamsters with TIH
associated intracellular bacteria, propagated in intestine 407 cells
(ATCC R© CCL-6
TM
), resulted in clinical disease (10). In 1993,
the bacteria associated with PE/PHE in pigs were successfully
propagated in rat small intestinal cells (IEC-18; ATCC R© CRL-
1589
TM
) under reduced oxygen level of 8% (11). Infected
cells were noted to spread the intracellular bacteria to their
daughter cells during cell division, which was not affected
by the presence of neomycin in the cell culture media. The
intracellular organism appeared 0.3µm in diameter and 1.0µm
in length, and was curved or rod shaped with a trilaminar
outer membrane (11). The cell culture propagated intracellular
organisms, devoid of any other bacteria including chlamydia,
were able to reproduce PHE in conventional pigs by oral infection
(12). Interestingly, gnotobiotic pigs could not be infected with
the same inoculum stock (12). However, in earlier experiments
gnotobiotic pigs could not only be successfully infected with
intestinal homogenate from naturally infected pigs, but also
developed clinical PHE (6). Pure IEC-18 cell cultures of the
intracellular bacterium obtained from naturally PHE affected
pigs were used to experimentally infect hamsters via the oral
route (13). Infected hamsters developed proliferative enteritis
showing the common etiology of the proliferative lesions (13).
The bacterium, designated ileal symbiont intracellularis (IS
intracellularis), was characterized as Gram-negative and acid-
fast positive using modified Ziehl Neelsen staining (14). The 16S
rRNA sequence of IS intracellularis showed the highest similarity
toDesulfovibrio desulfiricans, a sulfate reducing bacteria found in
anaerobic niches (14). Further confirmation of phenotypic and
genotypic characters led to the renaming of IS intracellularis to
L. intracellularis, in honor of Dr. G. H. K. Lawson who first
identified the intracellular bacteria in 1973 (15). L. intracellularis
is classified into the family Desulfovibrionacea and phylum
Proteobacteria (16). The organism was initially thought to have
no flagellum. However, later observations of L. intracellularis
outside of cells showed a unipolar flagellum used to achieve
a darting motion in the extracellular environment (16, 17).
Natural or experimental observation of L. intracellularis infection
has been observed in horses, rats, rabbits, ferrets, foxes, dogs,
sheep, deer, ratites, and non-human primates (16). Under natural
conditions, L. intracellularis is spread by the fecal-oral route of
infection (18). The organism is known to survive in fecal material
at 15◦C for up to 2 weeks (19).
Pathogenesis of L. intracellularis Infection
Clinical signs of L. intracellularis infection in pigs are often
characterized by acute diarrhea of varying severity and occasional
black tarry feces which can progress to watery diarrhea with
frank blood (2). Additional common observations include pallor,
weakness, and rapid death. Subclinical disease, often noticed
as variation in pig size, may be accompanied by sporadic
diarrhea, decreased growth rates, and potentially anorexia and
apathy (2). Monitoring of individual weight gain may help
in early identification of subclinical L. intracellularis infection.
Experimental oral inoculation of pigs with L. intracellularis leads
to establishment of infection of the intestinal epithelium after
3–5 days, with visible gross lesions appearing after 11–15 days
which may be present for another 14 days before resolution
(16, 17, 20, 21). The organism is shed in feces from around 7 days
after infection, and then for up to 12 weeks (2). Diarrhea starts at
9 days after infection and is observed for 21 days. L. intracellularis
antigen is observed in the epithelial cells of the distal small
intestine and the proximal large intestine until 28 days post-
infection. Macroscopic lesions consisting of thickening of the
intestinal wall with a ridged or cerebriform appearance, often
referred to as “hose like thickening,” are primarily observed in
the terminal ileum, but commonly extend up to 60 cm proximal
of the ileocecal valve into the first third of the proximal colon
(2, 22). Bloody intestinal content, occasionally with frank blood
clots, may be present. In severe cases the lesions may be present
in the jejunum, the cecum, and distal colon. Occasionally, lesions
can be limited to the large intestines (22). Histologic lesions
may be infrequently found in the spiral colon and also the
rectum. The crypt epithelial cells, especially those at the crypt-
villus junction (Figure 2), are thought to be infected first (20).
Infected epithelial cells spread the infection as they divide and
migrate. Marked hyperplastic proliferation of immature crypt
epithelial cells can be observed. Infected enterocytes accumulate
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FIGURE 1 | Major milestones in L. intracellularis research and control.
the organisms in the apical end (23). Heavily infected cells are
swollen and form protrusions, which are thought to mediate
bacterial spread into the lumen when microvilli are lost (23).
As the infection progresses, L. intracellularis organisms can also
be observed in macrophages located in the lamina propria, even
after the clearance of L. intracellularis antigen in epithelial cells
(20, 22). Therefore, macrophages are thought to play a role
in the spread of the infection (20, 22). Apoptotic epithelial
cells and macrophages appear in the healing stages of the
infection (23). It is now understood that apoptosis is not involved
in the pathogenesis of PE, even though contradicting views
were reported earlier (16, 21). A recent study suggests that
a combination of Notch-1 signaling and disruption of the β-
catenin/Wnt pathway may be associated with immature crypt
cell proliferation (24). Failure of crypt cells to differentiate
into goblet and absorptive cells results in a severe decrease
of MUC2 glycoprotein in the affected epithelium at the peak
of infection (24). Among studies investigating the host cell
response to L. intracellularis infection, a combined laser capture
microdissection and RNAseq was performed recently (25–
28). Research utilizing this meticulous approach identified that
infected enterocytes upregulate genes associated with the G1
phase of the cell cycle, resulting in activation of transcription and
protein biosynthesis (27). With the exception of copper uptake
transporters, genes associated with nutrient acquisition were
down regulated in infected enterocytes, which is thought to result
in malabsorptive diarrhea (27). Factors required for adherence,
entry and propagation of L. intracellularis in host cells, including
host cell proliferation and subsequent spread of the bacterium
to adjacent cells, are still unknown. Host adaptation of porcine
and equine L. intracellularis isolates is observed and their ability
to cause pathogenesis in heterologous hosts is limited (29).
Interestingly, porcine and equine host adapted L. intracellularis
strains can infect and induce pathogenesis in hamsters and
rabbits, respectively (30). Conversely, porcine isolates are not
pathogenic to rabbits and equine isolates are not pathogenic to
hamsters (30).
L. intracellularis Genome
Full genome sequences of two pathogenic pig isolates of
L. intracellularis (Table 1) are published to date (31, 32).
The genome consists of a 1.46Mb chromosome and three
plasmids of 0.03, 0.04, and 0.19Mb (32). Between the two
genomes, eight single-nucleotide polymorphisms (SNPs) and
70 insertion/deletions (indels) in intragenic regions have
been noted. In addition, 16 SNPs (3 synonymous, 13 non-
synonymous) and 20 indels were identified in intergenic regions.
A third genome of an equine isolate of L. intracellularis
(Table 1) was published in 2017 (32). An 18 kb prophage-
associated genomic island specific for porcine isolates has been
identified by comparative analysis of genomes (33). Since this
genomic island is not found in in vitro cultured L. intracellularis
PHE/MN1-00 after 60 passages (non-pathogenic) nor in equine
or rabbit isolates, it may not be required for pathogenicity in
pigs but rather be a feature of adaptation to the porcine host
(33). Genomic comparison of pathogenic passage 10 and non-
pathogenic passage 60 of isolate PHE/MN1-00 shows only four
SNPs in the chromosome and one SNP in plasmid C, apart from
the absence of the 18 kb prophage associated genomic island. The
lack of prominent differences at the genomic level suggests an
epigenetic regulation of virulence-associated genes in the course
of cell culture adaptation (33, 34). Comparative transcriptome
profiling of passages 10 and 60 of isolate PHE/MN1-00 revealed
401 genes that were exclusively expressed by the passage 10
bacterium and 319 genes that were expressed at both passage
levels (35). Interestingly, all plasmid A genes were repressed
in the non-pathogenic passage 60; these genes are implicated
in membrane transport, adaptation and stress response apart
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FIGURE 2 | L. intracellularis infection and gut ecology. Normal gut microbiome, beneficial microbes promoted by prebiotics and probiotics, adequate mucous layer
and protective antibodies confers resistance to L. intracellularis infection (left). A microbial ecology representative of “dysbiosis” characterized by depleted or altered
normal microbiota, inadequate intestinal mucus layer and low level of protective antibodies is observed in L. intracellularis infection (right).
TABLE 1 | List of complete genomes of L. intracellularis.
Genbank accession Isolate Host Year Institution
GCA_000055945.1 PHE/MN1-00 Pig 2003 University of Minnesota, Minnesota, USA
GCA_000331715.1 N343 Pig 2013 Moredun Research Institute, Midlothian, UK
GCA_001975945.1 E40504 Equine 2017 University of Minnesota, Minnesota, USA
from other biological functions, and included a few novel genes
with unknown functions. The isolate PHE/MN1-00 is predicted
to encode 1419 proteins [National Center for Biotechnology
Information (NCBI), Genome Assembly and Annotation report,
NCBI reference sequence NC_008011.1] and the isolate N343
[GenBank accession numbers CP004029 (chromosome) and
CP004030, CP004031 and CP004032] is predicted to encode
1339 proteins (31). Genes related to adhesion, invasion, virulence
are identified in the genome. Specifically, genes related to type
III secretion systems and type V autotransporter have been
noted (31). Only a few of these genes/proteins have been
experimentally analyzed. The genome also shows genes related
to adaptation to an intracellular life style, such as presence of a
putative ATP/ADP translocase gene, absence of genes involved
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in the tricarboxylic acid cycle, and synthesis of specific amino
acids (31).
The L. intracellularis genome was first sequenced in 2003,
but so far little-to-no information is available on the encoded
proteins. In 1998 it was found that the groES/EL operon of L.
intracellularis encodes a 60K Da GroEL protein which reacted
with L. intracellularis specific antisera raised in rabbits (36).
The L. intracellularis surface antigen A (LsaA) is expressed in
cell culture and in infected ileal tissue, and was identified using
degenerate primers (37). Monoclonal antibodies against LsaA
were able to block the in vitro infection of intestinal epithelial
cells by L. intracellularis. The gene for ATP/ADP translocase
of L. intracellularis, a protein known to be involved in energy
parasitism by intracellular pathogens, was identified based on
homology, and its functionality was verified by heterologous
expression in E. coli (38). In another study, L. intracellularis
secretion component N (lscN), lscO, and lscQ genes, a family of
virulence genes found in many bacteria which together encode a
putative type 3 secretion system, were found to be expressed in
infected pig intestinal epithelial cells (39). Further, recombinant
LscQwas found to react with serum from infected and vaccinated
pigs (39). Another protein, the L. intracellularis autotransporter
protein A (LatA), was identified based on mass spectrometric
analysis of cell culture expressed L. intracellularis proteins that
reacted with infected pig sera (40). LatA was shown to specifically
react to sera from infected pigs. Another mass spectrometry
study utilizing a shotgun proteomics approach identified five
outer membrane proteins of L. intracellularis, of which two were
antigenic and reacted with infected pig serum (41). A putative
hemolysin of L. intracellularis named LhlyA has been examined
at a preliminary level (42).
Control of L. intracellularis
Disinfectants
Various commercially available disinfectants based on
quaternary ammonium compounds (Roccal-D Plus R©, DC&R R©,
Synergize
TM
), aldehydes (DC&R R©, Synergize
TM
), oxidizing
agents (Virkon R© S), biguanindes (Nolvasan R© Solution),
phenol (Tek-Trol R©), iodine (Cetridine), chlorine, potassium
peroxymonosulfate, phosphate compounds (Stalosan R© F),
and sulfate compounds effectively inactivate L. intracellularis.
To allow bacterial inactivation the minimum contact time
is 10–30min in the presence of organic matter and a water
hardness of approximately 400 ppm calcium carbonate (43–45).
An increase in water hardness (1,000 ppm calcium carbonate)
slightly decreases the efficiency of inactivation of a few
disinfectants (43).
Antimicrobials
Utility of antibiotics in feed as a prophylaxis against PE/PHE
was appreciated from the early days of identification of
the clinical condition (18). With the advent of an in vitro
culture system for L. intracellularis, screening for antimicrobial
sensitivity using the rat enterocyte-based culture system (IEC-
18; ATCC R© CRL-1589
TM
) showed penicillin, erythromycin,
difloxacin, virginiamycin, and chlortetracycline had the highest
activity to inhibit bacterial multiplication followed by tiamulin
and tilmicosin (46). Many antibiotics such as tiamulin, tylosin,
tetracycline, lincomycin, and some quinoxalines are documented
to be effective at prophylactic doses to control L. intracellularis
infections (2, 47–54). Years of accumulated evidence indicate that
macrolides and pleuromutilins are the most effective prophylaxis
for PE/PHE (2). Subtherapeutic levels of antibiotic additives in
animal feed have been an integral part of pork production feeding
programs for more than 70 years (55). However, in the context
of worldwide concerns of antimicrobial resistance, reduction
or disuse of prophylactic antimicrobial growth promoters is
currently promoted in many parts of the world, including
the European Union (Regulation 1831/2003 of the European
parliament). Alternatives to control L. intracellularis have
become a practical requirement.
During clinical disease outbreaks, antibiotics such as
tylosin, enrofloxacin, tetracyclines, tiamulin, and tilmicosin
are commonly used at higher doses and are effective (2). On
the other hand, antimicrobial drugs known to be inherently
ineffective against clinical PE/PHE disease outbreaks include
penicillin, bacitracin, and aminoglycosides such as neomycin,
virginiamycin, and ionophores. In addition, other ineffective
antimicrobial therapies include copper or zinc compounds and
feed acidifiers (2).
Vaccines
It has been shown that natural infection with L. intracellularis
confers robust immunity (56). Specifically, pigs experimentally
infected with intestinal mucosal homogenate from naturally
infected pigs and treated with antibiotics from day 21 to 31
after infection showed complete resistance to reinfection on day
49, and lack of an acute phase response evidential of natural
immunity after primary infection (57, 58). L. intracellularis
specific cell mediated immunity and IgA in the intestinal
lumen were detected in infected pigs (59). Today, commercial
live attenuated and inactivated bacterin-based L. intracellularis
vaccines are available for prophylactic use (Figure 1), each
with its own advantages and disadvantages. The live attenuated
vaccine, administered orally via the drinking water, drench or
liquid feed based on farm specific feeding practices and regional
regulations, requires an antibiotic free window 3 days before and
after vaccination. Antibiotics do not interfere with the inactivated
vaccine but individual pig administration by parenteral route is
necessary. Maternal antibodies against L. intracellularis typically
wane off at 3 weeks, but may persist up to 5 weeks (60). Presence
of maternal antibodies after weaning does not interfere with the
immune response to live attenuated vaccines, but subsequent
protection has not been studied (61). A lag period of 3 to 4
weeks is observed between administration of live attenuated
vaccine and development of protective immunity (61). Due to
the longer commercial availability of the live attenuated vaccine,
more data on this product has been accumulated in the literature.
For example, it has been suggested that the immunity induced
by the live attenuated L. intracellularis vaccine is less efficient
than the immunity conferred by pathogenic L. intracellularis
infection due to the rapid induction of a L. intracellularis specific
IFNγ–T cell response by the latter (62). Based on correlation of
immunoglobulin levels in orally or intramuscularly vaccinated
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pigs with post-challenge lesions in the ileum and amount
of L. intracellularis shedding, neutralization is suggested as a
major mode of action of live attenuated vaccines (63). Oral,
intramuscular, or intraperitoneal route of vaccination with live
attenuated vaccine produces similar IgG response (64). However,
oral or intraperitoneal administration of the live attenuated
vaccine induces a significantly higher IgA response than the
intramuscular route of vaccination (64). Besides antibodies, other
mechanisms such as cell mediated immunity are also thought
to be elicited by the live attenuated vaccine as discussed above
(63, 64). Priming of the humoral immune response may be a
key mechanism of immunity induced by inactivated vaccines. In
summary, observations from the reports above indicate that both
humoral and cell mediated immunity are involved in protection
against L. intracellularis infection, and the quality of immune
response induced by vaccine strains of L. intracellularis differs
from that induced by pathogenic field isolates.
A perceived lack of immunity elicited by the live attenuated
vaccine was observed in pigs housed in bedded systems
(65). Also, the antibiotic free feed window required for
vaccine administration was unwelcome among the veterinarians
surveyed (65). Despite a few shortcomings, live attenuated and
inactivated L. intracellularis vaccines have been proven to be
beneficial in many trials, and are known to reduce lesions and
shedding associated with L. intracellularis infection in challenged
pigs (66–71). Furthermore, vaccination also reduces the usage
of antibiotics/antimicrobials to control L. intracellularis infection
(65, 72). However, L. intracellularis vaccines do not confer sterile
immunity and additional interventions to control PE/PHE may
be required (58, 73).
Other Alternatives
Nutritional supplements such as phytogenic ingredients, essential
oils, and others are now increasingly used in the control of
many animal diseases. Control of necrotic enteritis on the face
of disuse of antimicrobial growth promoters in poultry is a
prime example of this scenario (74–76). For this condition,
caused by the anaerobic bacterium Clostridium perfringens, a
perceived increase in morbidity and mortality was observed
after the removal of antimicrobial growth promoters (75). Many
alternate control measures such as prebiotics, probiotics, gut
acidifiers, and mannan oligosaccharides are now being used to
control necrotic enteritis, which could serve as a model for L.
intracellularis control (74, 75). Antimicrobial growth promoters
such as tylosin are widely used in L. intracellularis control (77,
78). They are known to promote a beneficial gut microbiome
and a transition to a “mature gut microbiome” (77, 78). Hence,
directly manipulating the gut microbiome with feed supplements
rather than antimicrobial growth promoters could be a viable
approach in L. intracellularis control.
Gut Microbiome and L. intracellularis
The human gut microbiome is well studied and is known to
consist of numerous species of bacteria ranging from 150 up
to 400 different species, mostly of Firmicutes, Bacteroidetes,
Actinobacteria, and Proteobacteria phyla (79, 80). The bacterial
diversity in the human gut is known to be influenced by age,
environment, diet content, fiber, cultural factors, host genetics,
and other factors (80). Patterns of gut microbiomes in human
populations are broadly described as falling under three non-
discrete “enterotypes” based on the taxonomic composition (80).
Enterotype 1 (or B) is described as dominated by Bacteroides,
enterotype 2 (or P) is dominated by Prevotella, and enterotype
3 (or F) is dominated by Firmicutes, most prominently
Ruminococcus (80). The Bacteroides and Prevotella are thought
to be inversely correlated in their relative abundance (80).
However, other groups suggest dynamic variation of enterotype
distribution in individuals in addition to variation due to analysis
of proportional data from microbiome studies (81, 82).
Pigs, apart from different dietary regimens, are very similar to
humans in their gut physiology and should have similar patterns
in gut microbiome development and maintenance. Preliminary
studies show that the pig gutmicrobiome varies from the jejunum
to the rectum, with the ileum having a higher relative abundance
of Firmicutes (83–87). In the cecum and colon, Firmicutes
and Bacteriodetes are comparable in relative abundance and
constitute the major phyla (85). Studies also clearly show that the
pig gut microbiome changes with age, described as “microbiota
succession,” and weaning has an profound impact on the piglets
gut microbiome, making them vulnerable to enteric infections
(85, 87). Under modern pig production conditions, piglets are
weaned at an age of 3–4 weeks, however the natural weaning age
of pigs is at 17 weeks and thus weaning is a major stress on the
pigs’ gastrointestinal tracts (87, 88).
A longitudinal study conducted in 2004 indicates that Danish
pigs showed a spurt of L. intracellularis shedding 2–3 weeks after
weaning, potentially suggesting a role of weaning stress on the
onset of L. intracellularis infection (89). It is now acknowledged
that L. intracellularis infection is common in weaned pigs (2). It is
also known that L. intracellularis infection leads to changes in the
pig gutmicrobiome, indicating a complex association (70, 90, 91).
Early studies show that experimental infection of pigs with a
cell culture propagated pure L. intracellularis inoculum does not
cause disease in gnotobiotic pigs but the same inoculum produces
disease in conventional pigs (12). In addition, gnotobiotic pigs
infected with neomycin treated mucosa from naturally infected
pigs showed L. intracellularis colonization and disease in the
small intestine, suggesting that L. intracellularis needs other
anaerobic organisms to establish infection (6, 17).
L. intracellularis infection is associated with a decrease in
mucus secreting goblet cells in the small intestinal epithelium
marked by absence of glycoprotein MUC2 expression at the peak
of infection (24). Mouse models lacking MUC2 expression are
susceptible to intestinal dysbiosis and infections (92). MUC2
knockout mice fed with probiotics show resistance to intestinal
dysbiosis and infections (92). On that note, manipulating the
gut microbiome with nutritional supplements may be helpful in
preventing the establishment of L. intracellularis infection and
may even assist in mitigating the effect of the pathogen in the
face of an infection.
Nutritional Intervention
In recent years, much attention has been given to nutritional
supplements, which could potentially aid in controlling
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L. intracellularis intestinal infections. Probiotics are defined
as “beneficial” bacteria that may confer a health benefit to
the host. On the other hand, prebiotics are food ingredients
that induce the growth or activity of probiotics. However, care
must be taken in labeling microorganisms as “beneficial,” as
available information is often anecdotal or bacterial strain or
host species specific. Nutritional changes may potentially be
useful in controlling L. intracellularis infection if hurdles such as
delivery of live organisms to the region of interest and others can
be overcome (93).
Prebiotics are prececal non-digestible contents present or
added in the feed that act as a substrate for certain intestinal
microbes, which in turn produce metabolites (such as short chain
fatty acids) and bacteriocins that modulate the gut microbiota,
gut morphology, immune system, and other beneficial effects
(94–96). In addition, the non-digestible fibers are thought
to physically prevent pathogen adhesion to host cells, a
mechanism which could potentially prevent the adhesion of
L. intracellularis to enterocytes. Fructooligosccharides, inulin,
and mannanoligosacchrides are some of the well-defined
prebiotic feed additives (94). Other resistant starch and complex
polysaccharides such as cellulose, hemicellulose, and pectin
are known for their prebiotic activity (95, 96). Feed trials in
pigs show that insoluble β-glucans present in barley favor an
increase in counts of gut bacteria such as Lactobacillus spp.
and Bifidobacterium spp., which are considered beneficial to the
gut health (97). Feed texture influences the nature and relative
content of intestinal microbiota in pigs. Coarse non-pelleted feed
decreases the prevalence of L. intracellularis and favors beneficial
microbes in experimentally and naturally infected pigs (90, 98).
Experimental addition of distiller dried grains with solubles
and soybean hulls to pig feed produced a mild mitigation of
experimental L. intracellularis infection (99–101). Experimental
supplementation of short-chain fructooligosaccharide (scFOS)
in the sow’s feed during the last third of gestation and the
entire lactation period resulted in improved general gut immune
parameters and L. intracellularis specific immune response in
their litters (102). These piglets also showed increase in goblet
cell number and healthier morphology of intestines compared to
the control litters without maternal scFOS feed supplementation.
The authors of the above study believe that maternal feeding
of scFOS may enhance the beneficial microbiota of the sows
which are then transmitted to the piglets, where the microbes
increase the production of short chain fatty acids in their
gut (102). Another recent study has produced preliminary
evidence that feed composition influences L. intracellularis
infections in farmed pigs (103). Though few specific studies
have investigated L. intracellularis control by using prebiotics,
this approach appears promising and is mediated by the
increase in beneficial microbes. In another similar approach,
supplementation of natural ingredients with direct antimicrobial
properties such as extracts of Origanum vulgaris (Oregano)
and Allium sativum (garlic) in pig feed produced reduction
in L. intracellularis load in the intestine and a decrease in
clinical disease, with improved production parameters in a herd
with history of L. intracellularis infection (104). Similar effects
were observed with a proprietary phytogenic feed additive with
essential oils and extracts in field study of a herd naturally
exposed to L. intracellularis (105). The maximum inclusion
level of non-digestible feed ingredients and phytogenic products
in the feed is an important consideration to avoid adversely
affecting the feed intake and available digestible energy in the
feed.
The benefits of fermented food for human consumption,
with or without live microbes, in improving gut health and
controlling enteric pathogens has been appreciated since ancient
times (106, 107). A scientific exposition of health benefits of
using Lactobacillus to manipulate the human gut microbiome
was reported in 1921 (108). Enterococcus faecium was shown
to suppress diarrhea and mortality induced by pathogenic
Escherichia coli in pigs (109). In regards to L. intracellularis,
addition of lactic acid to feed and fermented liquid feed
partially mitigated the pathogenesis and shedding of organism in
farmed pigs (110). Probiotics are administered as live organisms
or spores. They can resist gastric acids and bile, persist in
the intestinal tract, produce pathogen inhibitory compounds,
elicit an immune response, and alter the gut microbiome
composition and activity (111). Certain microbes may elicit
indirect benefits by triggering the mucosal innate immune
system in the alimentary passage, activating adaptive immune
response against antigenic motifs or molecular patterns shared
with pathogens, eliciting an anti-inflammatory state in the
intestinal epithelial barrier, and enhancing the barrier function
of epithelial cells lining the gut (112–115). Escherichia coliNissle,
considered a probiotic organism, enhances barrier function of
intestinal epithelia and improves protection against rotavirus
in pigs; a mechanism which could work in the context of L.
intracellularis infection (116). Some microbes are also known to
directly inhibit pathogenic microbiota by competitive exclusion,
secretion of various inhibitory biomolecules, and through
enzymes and metabolites; mechanisms potentially useful for
control L. intracellularis infection (114, 117). Others are known
to form biofilms that exclude pathogen colonization (114).
Compounds such as polymers of phosphates (PolyP), indole, and
competence and sporulation factors produced by Bacillus spp
are known to elicit beneficial innate immune responses in the
gut epithelium and also have systemic effects on the immune
system (117). The utility of feed supplements in controlling
L. intracellularis infection is an avenue left unexplored until
now.
CONCLUSIONS
It has been 25 years since L. intracellularis was first cultured
in vitro and 15 years since the genome was sequenced, but
understanding of the pathogenesis of this bacterium is still
not conclusive. However, beneficial attenuated oral vaccines
and inactivated vaccines are available to pig producers. The
host response to L. intracellularis infection is being gradually
unraveled, but the mechanism of L. intracellularis pathogenesis
and the virulence factors of the bacterium are not yet
definitively known. Information obtained from analysis of
gene expression patterns of pathogenic and nonpathogenic
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L. intracellularis and infected host cell gene expression profiles
need to be further explored. The proliferative lesions observed
with clinical L. intracelluaris infection are not yet replicated
in any in vitro infection model. The inability of pure culture
of L. intracellularis to establish infection in gnotobiotic pigs
remains an unexplained observation and would lend clues to
the microbial milieu that favors L. intracellularis to establish
infection. While PPE is observed in weaned and growing
pigs and PHE is observed in pigs over 4 months of age,
the reason behind this variation in pathogenesis with age is
not known. Hamsters, which show susceptibility to the pig L.
intracellularis and develop pathological lesions similar to that
in pigs, could be utilized as a model to further study the
disease ecology of L. intracellularis under gnotobiotic conditions.
Understanding the dynamics between the gut microbiome and
L. intracellularis infection will help in formulating appropriate
diet-based control of the disease, which would be synergistic with
current vaccines.
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